The results revealed a significant increase in merged fluorescence intensity of Serpin E1 and CK18 in both subcutaneous and peritoneal tumors co-injected with GC cells and Serpin E1-overexpressed fibroblasts compared to those co-injected with GC cells and control fibroblasts (Fig. 5A, B). This evidence concerns the gene SERPINE1 and gastric cancer.